23 May 2013
Keywords: provalis, signs, vaccine, option, deal, aventis, pasteur
Article | 20 December 2004
UK-based Provalis has signed an option agreement with Aventis Pasteur, the vaccine unit of French drug major Sanofi-Aventis, for the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 December 2004
© 2013 thepharmaletter.com